Chang et al. confirmed that immuno-adjuvant therapy with anti-PD-1, anti-PD-L1 and anti-CTLA-4 antibodies reversed sepsis-induced immunosuppression and improved survival in mice [117]. The gene discussed is CTLA4; the disease is Sepsis.